Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 19 for:    ALT-02

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00006089
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : July 31, 2019
Sponsor:
Collaborator:
Gynecologic Oncology Group
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 4, 2007
Actual Study Completion Date : January 31, 2010